We observed markedly higher levels of PSMD1 and PSMD3 mRNA in CML patients who had progressed to the blast phase compared with the chronic phase of the disease. This evidence concerns the gene PSMD3 and chronic myelogenous leukemia, BCR-ABL1 positive.